Skip to main content
Log in

Submission of clinical studies to ethics committees or clinical trials registers: the authors’ point of view

  • Brief Report
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

To evaluate the satisfaction of clinical scientists when submitting study drafts to an ethics committee/clinical trials register (CLINICALTRIALS, EUDRACT, ISRCTN) we conducted an online survey of 240 authors publishing in anesthesia/critical care medicine (A) or in major general medical (M) journals from January to December 2007. No statistical difference between groups A and M was seen with regard to the number of studies submitted to ethics committees or registered in various clinical trials registers. On a visual analogue scale (VAS −10 to +10), the subjective evaluation of the effort required to submit a study draft to an ethics committee or enter it in a clinical trials register produced almost only negative grades in both groups. The mean different perceptions ranged from −3.5 to −0.1 in group A and from −4.4 to −0.2 (except for +0.1 and 1.9 in 2 subgroups) in group M. The authors in both groups gave a positive score to the better transparency in scientific research resulting from introduction of the clinical trials registers (+2.4 in group A, +4.8 in group M). The results of our study indicate widespread author dissatisfaction when submitting a clinical trial to ethics committees or clinical trials registers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Hopewell S, Clarke M, Stewart L, Tierney J (2007) Time to publication for results of clinical trials. Cochrane Database Syst Rev 18:MR000011

    Google Scholar 

  2. European Parliament. Directive 2001/20/EC on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal of the European Communities, Brussels, 1 May 2001

  3. Wald DS (2004) Bureaucracy of ethics applications. Br Med J 329:282–284

    Article  Google Scholar 

  4. Yusuf S (2004) Randomized clinical trials: slow death by a thousand unnecessary policies? Can Med Assoc J 171:889–892

    Article  Google Scholar 

  5. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB, International Committee of Medical Journal Editors (2004) Clinical trial registration. A statement from the International Committee of Medical Journal Editors. Ann Intern Med 141:477–478

    PubMed  Google Scholar 

  6. Schwarz S, Frölich L, Striebel JP, Hennerici MG (2007) The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials? Dtsch Med Wochenschr 132:108–112

    Article  PubMed  CAS  Google Scholar 

  7. Sheridan DJ (2006) Reversing the decline of academic medicine in Europe. Lancet 367:1698–1701

    Article  PubMed  Google Scholar 

  8. Lambers Heerspink HJ, Dobre D, Hillege HL, Grobbee DE, de Zeeuw D (2008) Does the European Clinical Trials Directive really improve clinical trial approval time? Br J Clin Pharmacol 66:546–550

    Article  PubMed  Google Scholar 

  9. Cressey D (2008) Researchers see a need for speed in EU trial approvals. Nat Med 14:794

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arnulf Benzer.

Additional information

This article is discussed in the editorial available at: doi: 10.1007/s00134-009-1435-2.

All authors have contributed equally to the study.

Appendix

Appendix

See Table 1.

Table 1 PubMed search terms used for retrieval and selection of papers

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pehboeck, D., Hohlrieder, M., Wenzel, V. et al. Submission of clinical studies to ethics committees or clinical trials registers: the authors’ point of view. Intensive Care Med 35, 713–716 (2009). https://doi.org/10.1007/s00134-009-1434-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-009-1434-3

Keywords

Navigation